Literature DB >> 17443727

Prognostic impact of positive lymph node ratio in gastric carcinoma.

Orhan Celen1, Emin Yildirim, Uğur Berberoglu.   

Abstract

BACKGROUND AND OBJECTIVES: To evaluate the prognostic value of metastatic lymph node ratio in gastric carcinoma.
METHODS: One hundred and sixty four patients who underwent D(2) dissection for gastric carcinoma at Ankara Oncology Hospital were reviewed retrospectively. The prognostic factors including Japanese classification, AJCC/UICC TNM classification and metastatic lymph node ratio (1-10% and >10%) were evaluated in univariate and multivariate Cox regression analysis.
RESULTS: The multivariate analysis showed that Borrmann classification, pN-category of AJCC/UICC classification and metastatic lymph node ratio were the most significant prognostic factors and a higher hazard ratio was obtained for metastatic lymph node ratio than pN category of AJCC/UICC classification (4.5 vs. 11.4). When the metastatic ratio groups of 1-10% and >10% were subdivided into pN(1), pN(2) and pN(3) categories of the AJCC/UICC classification, there was no statistical difference between survival curves. When pN(1), pN(2) and pN(3) categories of the AJCC/UICC classification were subdivided into the ratio groups of 1-10% and >10%, the survival rate of ratio group 1-10% was better than ratio group >10%.
CONCLUSION: With its simplicity and reproducibility, metastatic lymph node ratio can be used as a reliable prognostic indicator.

Entities:  

Mesh:

Year:  2007        PMID: 17443727     DOI: 10.1002/jso.20797

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  21 in total

1.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

4.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

5.  Prognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection.

Authors:  Jia Xu; Yu-Hai Bian; Xin Jin; Hui Cao
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

6.  Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer.

Authors:  Sung Ryol Lee; Hyung Ook Kim; Byung Ho Son; Jun Ho Shin; Chang Hak Yoo
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

7.  Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?

Authors:  Paolo Aurello; Niccolò Petrucciani; Giuseppe R Nigri; Marco La Torre; Paolo Magistri; Simone Tierno; Francesco D'Angelo; Giovanni Ramacciato
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

8.  Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.

Authors:  Pengfei Gu; Jingyu Deng; Zhe Sun; Zhenning Wang; Wei Wang; Han Liang; Huimian Xu; Zhiwei Zhou
Journal:  Surg Today       Date:  2020-08-04       Impact factor: 2.549

9.  Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.

Authors:  Hua-Chuan Zheng; Koichi Tsuneyama; Hiroyuki Takahashi; Shigeharu Miwa; Toshiro Sugiyama; Boryana Konstantinova Popivanova; Chifumi Fujii; Kazuhiro Nomoto; Naofumi Mukaida; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-18       Impact factor: 4.553

10.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.